Novel oral pathways in LDL-c lowering therapy: The new promise of CETPi10' education - Oct. 17, 2023 - Erin Michos, MD - Baltimore, MD, USA
Video navigation menu
- Mechanism of CETPi 00:37
- Summary of previous CETPi 03:11
- Studies with obicetrapib 06:24
This lecture by FErin Michos, MD was part of the EBAC-accredited symposium "The LDL-c challenge in high cardiovascular risk: Integrating innovative therapies in clinical management" held during the ESC congress 2023.
Erin Michos is an Associate Professor in the Division of Cardiology at the Johns Hopkins School of Medicine, with joint appointment in Epidemiology at the School of Public Health. She is the Director of Women’s Cardiovascular Health and the Associate Director of Preventive Cardiology at Johns Hopkins University.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Amgen, NewAmsterdam Pharma, Sanofi and Viatris.